<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations/><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/31AF7C42-D7C4-47FF-A5D8-19AADBAD30A9"><gtr:id>31AF7C42-D7C4-47FF-A5D8-19AADBAD30A9</gtr:id><gtr:name>MRC Human Immunology Unit</gtr:name><gtr:address><gtr:line1>Weatherall Inst of Molecular Medicine</gtr:line1><gtr:line2>John Radcliffe Hospital</gtr:line2><gtr:line3>Headington</gtr:line3><gtr:line4>Oxford</gtr:line4><gtr:postCode>OX1 9DS</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/31AF7C42-D7C4-47FF-A5D8-19AADBAD30A9"><gtr:id>31AF7C42-D7C4-47FF-A5D8-19AADBAD30A9</gtr:id><gtr:name>MRC Human Immunology Unit</gtr:name><gtr:address><gtr:line1>Weatherall Inst of Molecular Medicine</gtr:line1><gtr:line2>John Radcliffe Hospital</gtr:line2><gtr:line3>Headington</gtr:line3><gtr:line4>Oxford</gtr:line4><gtr:postCode>OX1 9DS</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/65CF431F-3B89-4644-9ECB-ABF60D41526A"><gtr:id>65CF431F-3B89-4644-9ECB-ABF60D41526A</gtr:id><gtr:firstName>John</gtr:firstName><gtr:surname>Bell</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/A9A12AFB-52DD-481B-A639-8F98B1C69AA1"><gtr:id>A9A12AFB-52DD-481B-A639-8F98B1C69AA1</gtr:id><gtr:firstName>Andrew</gtr:firstName><gtr:otherNames>J</gtr:otherNames><gtr:surname>McMichael</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=MC_U137884178"><gtr:id>EB11523A-693D-41CC-810C-A061E7E4E041</gtr:id><gtr:title>Immune receptors: biochemical, structural and genetic analysis</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Intramural</gtr:grantCategory><gtr:grantReference>MC_U137884178</gtr:grantReference><gtr:abstractText>Exactly how humans respond to a virus such as influenza is largely genetically determined by the tissue (HLA) type. This is because the HLA protein molecules on the cell surface select the parts of the virus to present to the immune system. The T lymphocytes that recognise the HLA-virus combination are stimulated to grow and destroy the virus. Those that recognise the virus best grow best and this programme is exploring exactly what is a strong binding interaction between the receptor on a T lymphocyte and an HLA-virus combination. The commonest immune response to influenza virus is being studied.</gtr:abstractText><gtr:technicalSummary>This programme is a collaboration with Professors Yvonne Jones and David Stuart (WTHG) and Anton van der Merwe (Sir William Dunn School).||The aim is to understand how immunodominant T cell receptors (TCR) interact with their target HLA-peptide antigen and how this selects the most favourable T cell response. The work has concentrated on the TCR specific for the influenza matrix protein peptide presented by HLA-A2. The receptor used is virtually the same in all people with HLA-A2, the most common HLA type.||The crystal structure of this receptor complexed to HLA-A2 plus peptide was determined.||Then mutations were made in the receptor at sites that appear critical for the interaction and the relative importance of each of these was determined using surface plasmon resonance to measure the thermodynamic characteristics of each mutant receptor.||Thus a very complete view of how the receptor interacts with its ligand has been built up and this demonstrates the features that make this receptor so immunodominant and account for its strong selection in humans during and after their first encounter with influenza virus.||Currently selected mutant receptors are being expressed in cells and mice in order to relate the in vitro findings to in vivo T cell behaviour.||Experimental design - Molecular biology, protein chemistry, cellular immunology||a) tissues, cells, animals used - Human T cells||b) techniques/approaches - Immunology, binding measurements; crystallography; monoclonal antibodies; plasmon resonance||c) measurements/outcomes - Characterisation of cell surface receptor function</gtr:technicalSummary><gtr:fund><gtr:end>2010-03-31</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>1998-10-01</gtr:start><gtr:type>EXPENDITURE_ACTUAL</gtr:type><gtr:valuePounds>408049</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs/><gtr:disseminationOutputs/><gtr:exploitationOutputs/><gtr:furtherFundingOutputs/><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs/><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>8A9AC7D3-7A54-44B0-A120-EA53FBA4B07E</gtr:id><gtr:title>Some lessons from the systematic production and structural analysis of soluble (alpha)(beta) T-cell receptors.</gtr:title><gtr:parentPublicationTitle>Journal of immunological methods</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0410f5fd9b779a7cd94e46d263d446ba"><gtr:id>0410f5fd9b779a7cd94e46d263d446ba</gtr:id><gtr:otherNames>van Boxel GI</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0022-1759</gtr:issn><gtr:outcomeId>CAB232E2B7B</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>87F686AF-00C4-46BC-A696-DDC5D0777012</gtr:id><gtr:title>DNA repair is limiting for haematopoietic stem cells during ageing.</gtr:title><gtr:parentPublicationTitle>Nature</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/70395f5a69bfb602d420ba8df5e7abaa"><gtr:id>70395f5a69bfb602d420ba8df5e7abaa</gtr:id><gtr:otherNames>Nijnik A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0028-0836</gtr:issn><gtr:outcomeId>54E4E0DE322</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>BBE6008F-6EE5-4A72-B642-8E66684D1A4D</gtr:id><gtr:title>Multiple sclerosis susceptibility and the X chromosome.</gtr:title><gtr:parentPublicationTitle>Multiple sclerosis (Houndmills, Basingstoke, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8a32bbd11c23d7a64aed2c75a9fcbe74"><gtr:id>8a32bbd11c23d7a64aed2c75a9fcbe74</gtr:id><gtr:otherNames>Herrera BM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>1352-4585</gtr:issn><gtr:outcomeId>C2D516BEED9</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9E20FD45-763A-47B2-A679-EBD41C5A031C</gtr:id><gtr:title>First steps towards effective methods in exploiting high-throughput technologies for the determination of human protein structures of high biomedical value.</gtr:title><gtr:parentPublicationTitle>Acta crystallographica. Section D, Biological crystallography</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/eafd81fb2fff553b9918a8057b672855"><gtr:id>eafd81fb2fff553b9918a8057b672855</gtr:id><gtr:otherNames>Banci L</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>0907-4449</gtr:issn><gtr:outcomeId>285F6513E4F</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>04750D9A-B87D-4BE8-ABC4-7FBC0813F783</gtr:id><gtr:title>Cardiac structure and function during ageing in energetically compromised Guanidinoacetate N-methyltransferase (GAMT)-knockout mice - a one year longitudinal MRI study.</gtr:title><gtr:parentPublicationTitle>Journal of cardiovascular magnetic resonance : official journal of the Society for Cardiovascular Magnetic Resonance</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/785c5767a062f5c8277822ade76b715a"><gtr:id>785c5767a062f5c8277822ade76b715a</gtr:id><gtr:otherNames>Schneider JE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>1097-6647</gtr:issn><gtr:outcomeId>7F07D853676</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>DCCB6F65-4816-4C0E-86CF-B967690E451E</gtr:id><gtr:title>From genes to function: the next challenge to understanding multiple sclerosis.</gtr:title><gtr:parentPublicationTitle>Nature reviews. Immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/dfd30e9e606c194dffc5c461b84c98d6"><gtr:id>dfd30e9e606c194dffc5c461b84c98d6</gtr:id><gtr:otherNames>Fugger L</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1474-1733</gtr:issn><gtr:outcomeId>3B850EB5D52</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>62061D91-E2E2-490F-B02E-8515B5D04A7C</gtr:id><gtr:title>Crystallization and preliminary X-ray structural studies of a Melan-A pMHC-TCR complex.</gtr:title><gtr:parentPublicationTitle>Acta crystallographica. Section F, Structural biology and crystallization communications</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/26a376d7a44129a40b0d1acd302b269f"><gtr:id>26a376d7a44129a40b0d1acd302b269f</gtr:id><gtr:otherNames>Yuan F</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>1744-3091</gtr:issn><gtr:outcomeId>B8A42E90E82</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>1B9B4692-4270-4C0A-827F-1FCC0AA8022F</gtr:id><gtr:title>Computational design and crystal structure of an enhanced affinity mutant human CD8 alphaalpha coreceptor.</gtr:title><gtr:parentPublicationTitle>Proteins</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1e63e74c220ec196eca0bf3c62165deb"><gtr:id>1e63e74c220ec196eca0bf3c62165deb</gtr:id><gtr:otherNames>Cole DK</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0887-3585</gtr:issn><gtr:outcomeId>208B7E6243E</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5EF48CF5-260D-43B2-9E0C-FD8164BAC636</gtr:id><gtr:title>Peptide-major histocompatibility complex dimensions control proximal kinase-phosphatase balance during T cell activation.</gtr:title><gtr:parentPublicationTitle>The Journal of biological chemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e99e1403250d64eb353ef98a4ef6fb83"><gtr:id>e99e1403250d64eb353ef98a4ef6fb83</gtr:id><gtr:otherNames>Choudhuri K</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0021-9258</gtr:issn><gtr:outcomeId>921C98FFC07</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2A727F52-FFF7-43A2-A244-E1AE0B0A47A5</gtr:id><gtr:title>Rational development of high-affinity T-cell receptor-like antibodies.</gtr:title><gtr:parentPublicationTitle>Proceedings of the National Academy of Sciences of the United States of America</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a3bd7185a0698864c4440b2dbd1fed93"><gtr:id>a3bd7185a0698864c4440b2dbd1fed93</gtr:id><gtr:otherNames>Stewart-Jones G</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0027-8424</gtr:issn><gtr:outcomeId>1C59AAB5109</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E2DE3343-3105-440F-9AF3-5CF89620FE8D</gtr:id><gtr:title>Antigen processing influences HIV-specific cytotoxic T lymphocyte immunodominance.</gtr:title><gtr:parentPublicationTitle>Nature immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a7271d887d655ab8bf8e880119ff2237"><gtr:id>a7271d887d655ab8bf8e880119ff2237</gtr:id><gtr:otherNames>Tenzer S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1529-2908</gtr:issn><gtr:outcomeId>97EB83056F8</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7C398F8A-D3B6-46C1-9903-BC6814D6224D</gtr:id><gtr:title>Strong TCR conservation and altered T cell cross-reactivity characterize a B*57-restricted immune response in HIV-1 infection.</gtr:title><gtr:parentPublicationTitle>Journal of immunology (Baltimore, Md. : 1950)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6f5491b386d455aa4032571d48e83937"><gtr:id>6f5491b386d455aa4032571d48e83937</gtr:id><gtr:otherNames>Gillespie GM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>0022-1767</gtr:issn><gtr:outcomeId>BC812D75B23</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>3F51974C-3E62-4F30-B63C-5AAC0CB14CD8</gtr:id><gtr:title>Humidity control as a strategy for lattice optimization applied to crystals of HLA-A*1101 complexed with variant peptides from dengue virus.</gtr:title><gtr:parentPublicationTitle>Acta crystallographica. Section F, Structural biology and crystallization communications</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ef361cc945b0f0ed648474bcfc22a0d3"><gtr:id>ef361cc945b0f0ed648474bcfc22a0d3</gtr:id><gtr:otherNames>Chotiyarnwong P</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>1744-3091</gtr:issn><gtr:outcomeId>BEAD59FB280</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>10E8408D-DC41-434A-8BF8-BC0B4AC0454C</gtr:id><gtr:title>Opposing effects of HLA class I molecules in tuning autoreactive CD8+ T cells in multiple sclerosis.</gtr:title><gtr:parentPublicationTitle>Nature medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a77fb0f2314c03a96d151763fa8313dc"><gtr:id>a77fb0f2314c03a96d151763fa8313dc</gtr:id><gtr:otherNames>Friese MA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>1078-8956</gtr:issn><gtr:outcomeId>16D60974D97</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2999BA60-4F94-470F-9252-10C9251B6AFD</gtr:id><gtr:title>Human TCR-binding affinity is governed by MHC class restriction.</gtr:title><gtr:parentPublicationTitle>Journal of immunology (Baltimore, Md. : 1950)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1e63e74c220ec196eca0bf3c62165deb"><gtr:id>1e63e74c220ec196eca0bf3c62165deb</gtr:id><gtr:otherNames>Cole DK</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0022-1767</gtr:issn><gtr:outcomeId>8CC79DB41F5</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7886F16F-A7BC-4D34-B478-EAFC828A3B52</gtr:id><gtr:title>The structural dynamics and energetics of an immunodominant T cell receptor are programmed by its Vbeta domain.</gtr:title><gtr:parentPublicationTitle>Immunity</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/7cd735d2c7ec2a06f5c43d6198a3ebae"><gtr:id>7cd735d2c7ec2a06f5c43d6198a3ebae</gtr:id><gtr:otherNames>Ishizuka J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>1074-7613</gtr:issn><gtr:outcomeId>6B681F2D91E</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2969A8C5-A185-478E-AA3F-5C354948F7CD</gtr:id><gtr:title>Parental transmission of HLA-DRB1*15 in multiple sclerosis.</gtr:title><gtr:parentPublicationTitle>Human genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9b76c8aca5550da4a9dad29ded472960"><gtr:id>9b76c8aca5550da4a9dad29ded472960</gtr:id><gtr:otherNames>Ramagopalan SV</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0340-6717</gtr:issn><gtr:outcomeId>17D5F56DE6D</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>77278C53-A7F3-43D6-95BC-CFE1A4515FFE</gtr:id><gtr:title>A single amino acid defines cross-species reactivity of tree shrew (Tupaia belangeri) CD1d to human invariant natural killer T (iNKT) cells.</gtr:title><gtr:parentPublicationTitle>Immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3ebd6bdb2f296d2afe5cc783a781edfc"><gtr:id>3ebd6bdb2f296d2afe5cc783a781edfc</gtr:id><gtr:otherNames>Zhang P</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0019-2805</gtr:issn><gtr:outcomeId>165E30CD739</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>1677DF87-3F76-4C1D-A4FD-AA4C470CC43C</gtr:id><gtr:title>MHC-peptide-specific antibodies reveal inefficient presentation of an HLA-A*0201-restricted, Melan-A-derived peptide after active intracellular processing.</gtr:title><gtr:parentPublicationTitle>European journal of immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/bc6513a22150450d62eea3bbff9d2e80"><gtr:id>bc6513a22150450d62eea3bbff9d2e80</gtr:id><gtr:otherNames>Held G</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0014-2980</gtr:issn><gtr:outcomeId>B5969E00D83</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>3C084F70-22E3-4889-BF78-91022B6804B4</gtr:id><gtr:title>The structure of the human allo-ligand HLA-B*3501 in complex with a cytochrome p450 peptide: steric hindrance influences TCR allo-recognition.</gtr:title><gtr:parentPublicationTitle>European journal of immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/dd9cdb41b63b19f1798d264e04b29a65"><gtr:id>dd9cdb41b63b19f1798d264e04b29a65</gtr:id><gtr:otherNames>Hourigan CS</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>0014-2980</gtr:issn><gtr:outcomeId>4CBD019B2DD</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">MC_U137884178</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>C6D70A71-8796-47BC-AFE0-CC2286E66A06</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Inflammatory and Immune System</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>CF950C9A-DB16-4E23-8AEB-94548777BCA1</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>1.1  Normal biological development and functioning</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>